Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Net Income (2022 - 2025)

Historic Net Income for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.

  • CervoMed's Net Income fell 6263.68% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11415.39%. This contributed to the annual value of -$16.3 million for FY2024, which is 11452.27% down from last year.
  • As of Q3 2025, CervoMed's Net Income stood at -$7.7 million, which was down 6263.68% from -$6.2 million recorded in Q2 2025.
  • CervoMed's 5-year Net Income high stood at -$1.2 million for Q2 2023, and its period low was -$7.7 million during Q3 2025.
  • Over the past 4 years, CervoMed's median Net Income value was -$2.8 million (recorded in 2022), while the average stood at -$3.8 million.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 4205.55% in 2023, then tumbled by 18404.8% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Net Income stood at -$4.1 million in 2022, then surged by 42.06% to -$2.4 million in 2023, then tumbled by 184.05% to -$6.7 million in 2024, then decreased by 15.16% to -$7.7 million in 2025.
  • Its Net Income stands at -$7.7 million for Q3 2025, versus -$6.2 million for Q2 2025 and -$4.9 million for Q1 2025.